Know Cancer

or
forgot password
  • cancer clinical trials in connecticut

  • Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    The Hospital of Central Connecticut

    Trial Locations
    The Hospital of Central Connecticut
    Yale University
    Stamford Hospital
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Norwalk Hospital
    Norwalk, Connecticut 06856
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Breast Neoplasms
    Sorafenib Long Term Extension Program (STEP)

    New Britain, Connecticut 06052
    Neoplasms
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Oncology Associates P.C.-Avon

    Trial Locations
    Oncology Associates P.C.-Avon
    Bridgeport Hospital
    Medical Specialists of SWIM
    Medical Specialists of Fairfield
    Oncology Associates of Bridgeport-Fairfield
    Medical Oncology and Hematology, P.C.
    Hartford Hospital
    Connecticut Multi Specialty Group-Hartford
    Oncology Associates P.C.-Hartford
    Medical Oncology & Hematology, P.C.
    Eastern Connecticut Hematology & Oncology Associates
    Black Rock Medical Group
    Oncology Associates of Bridgeport-Trumbull
    Connecticut Multi Specialty Group-Wethersfield
    Oncology Associates P.C.-Willimantic
    Breast Cancer
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Bridgeport Hospital

    Trial Locations
    Bridgeport Hospital
    Dept Of Internal Med, Sect Of Pulmonary & Critical Care Med
    Venous Thrombosis
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Leukemia
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus

    Trial Locations
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    William W. Backus Hospital
    Esophageal Cancer
    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
    Bendheim Cancer Center at Greenwich Hospital

    Trial Locations
    Bendheim Cancer Center at Greenwich Hospital
    Norwalk Hospital
    Eastern Connecticut Hematology and Oncology Associates
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Breast Cancer, Fatigue, Sleep Disorders
    Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
    Greenwich Hospital - Bendheim Cancer Center

    Trial Locations
    Greenwich Hospital - Bendheim Cancer Center
    Cancer Center of Central Connecticut
    Hematology Oncology P.C.
    Oncology Association of Bridgeport-Bridgeport-US
    Medical Oncology and Hematology
    Breast Cancer
    FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Gastroesophageal Cancer, Gastric Cancer
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis Hospital and Medical Center
    Middlesex Hospital
    The Hospital of Central Connecticut
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Middlesex Hospital

    Trial Locations
    Middlesex Hospital
    The Hospital of Central Connecticut
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Myeloma
    Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    Middlesex Hospital
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale Cancer Center
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Advanced Breast Cancer
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia